# Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

Study · id `cardio:ct-nct06308952` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06308952](<https://clinicaltrials.gov/study/NCT06308952>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06308952

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 354 participants.

## Technical summary

Registry record NCT06308952. Randomized; quadruple masking; primary purpose prevention. Start 2024-07-30 (actual); primary completion 2027-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 354 participants (planned count; ClinicalTrials.gov record NCT06308952, source copy `cardio:ctgov-nct06308952-2026-03-03`, retrieved 2026-10-26)
- Started: 2024-07-30 (actual) (ClinicalTrials.gov record NCT06308952, source copy `cardio:ctgov-nct06308952-2026-03-03`, retrieved 2026-10-26)
- Primary completion: 2027-12-01 (anticipated) (ClinicalTrials.gov record NCT06308952, source copy `cardio:ctgov-nct06308952-2026-03-03`, retrieved 2026-10-26)
- Completion: 2027-12-31 (anticipated) (ClinicalTrials.gov record NCT06308952, source copy `cardio:ctgov-nct06308952-2026-03-03`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT06308952, source copy `cardio:ctgov-nct06308952-2026-03-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06308952-2026-03-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation
- Condition: Cerebrovascular Event
- Condition: Stent Stenosis
- Condition: Ischemic Stroke
- Condition: Hemorrhagic Stroke
- Condition: Stent Thrombosis
- Condition: Death, Brain
- Condition: Endothelial Dysfunction
- Intervention (Drug): Atorvastatin 20mg
- Lead sponsor: Duan Chuanzhi
- Lead sponsor class: OTHER
- Collaborator: Shenzhen Second People's Hospital
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Harbin Medical University
- Collaborator class: OTHER
- Collaborator: ZhuHai Hospital
- Collaborator class: OTHER
- Collaborator: First Hospital of Shijiazhuang City
- Collaborator class: OTHER
- Collaborator: Eighth Affiliated Hospital, Sun Yat-sen University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Jinan University
- Collaborator class: OTHER
- Collaborator: Dongguan Kanghua Hospital
- Collaborator class: OTHER
- Collaborator: Beijing Tiantan Hospital
- Collaborator class: OTHER
- Collaborator: Guangdong 999 Brain Hospital
- Collaborator class: OTHER
- Collaborator: The First Affiliated Hospital of Zhengzhou University
- Collaborator class: OTHER
- Collaborator: First Affiliated Hospital of Chongqing Medical University
- Collaborator class: OTHER
- Collaborator: Dongguan People's Hospital
- Collaborator class: OTHER\_GOV
- Collaborator: Xinqiao Hospital of Chongqing
- Collaborator class: OTHER
- Collaborator: Shanxi Cardiovascular Hospital
- Collaborator class: OTHER
- Collaborator: Peking Union Medical College Hospital
- Collaborator class: OTHER
- Collaborator: Tianjin Huanhu Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Atorvastatin (`cardio:atorvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)

## Registry records

Records a program assembled from a public registry; no person wrote or checked them. They are counted here, not listed: the JSON record of this page lists each one in its relationships.

- 13 registry organizations

## Provenance

Content hash: df847e76f9391a23aab949b3e2d0fcacc5deaf97dd18c36a8aec3c57dc243543
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
